News & Articles
Selected Filters:
Thermo Fisher Scientific launches collection kit to streamline saliva testing
The self-collection kits facilitate raw saliva collection to aid global SARS-CoV-2 research and surveillance efforts
Biomimetics hold the key to the future of multiuse plastics
In this guest editorial, Michaël van der Jagt, CEO of Parx Materials, discusses how the human immune system can inspire innovation
Avacta announces AffiDX SARS-CoV-2 antigen lateral flow test detects Delta variant
The clinical data for Avacta’s AffiDX SARS-CoV-2 antigen lateral flow test demonstrated 100% sensitivity
Abbott’s Panbio Rapid Antigen Self-Test receives CE mark, increasing access to fast, reliable COVID-19 testing in the United Kingdom
The Panbio self-test features a minimally invasive nasal swab and delivers results in as early as 15 minutes with no instrumentation, using proven Abbott lateral flow technology
VIVEbiotech launches lentiviral vector manufacturing plant for cell and gene therapy sector
The facility will be capable of manufacturing batches ranging from those for early-stage research to GMP for clinical and future commercial uses
Tecan acquires Paramit Corporation
New England Biolabs launches Primer Monitor Tool for tracking SARS-CoV-2 variants that may impact primers used in diagnostic assays
This open access tool, powered by data supplied by GISAID, provides virologists and COVID-19 test developers insight to the latest viral variants and primer designs used around the world
Meet the winners of the 2021 Scientists’ Choice Awards for Clinical Science
Scientific, technological and communications excellence has been celebrated at the Clinical Science Summit, with Beckman Coulter, Zymo Research, and PerkinElmer among those recognized
Population-wide immune responses to SARS-CoV-2: Insights from quantifying the antibody response
Watch this on-demand webinar to discover a new approach to profiling antibody responses by quantifying affinity and concentration
RedHill Biopharma announces presentation of positive oral Opaganib Phase 2 data in COVID-19
The drug candidate was associated with a reduction in the need for supplemental oxygen support, earlier time to discharge from hospital and was well tolerated
One year’s experience of large-scale SARS-CoV-2 testing in Luxembourg: Your questions answered
Learn about the large scale COVID-19 PCR testing program set up by the government of Luxembourg
Thermo Fisher Scientific launches CE-IVD-marked COVID-19 test
Updated version of highly sensitive and accurate COVID-19 PCR kit accounts for known and future viral mutations
Why serology tests are shaping the future of vaccine development
Learn more about the efficient and reproducible multiplex immunoassays set to change the way COVID-19 researchers profile antibody response
Protein identified as new therapeutic anti-viral target for COVID-19
The research also found the presence of detectable viral RNA in blood in COVID-19 patients is a strong predictor of mortality
NHS opens eight UK clinical trial sites to assess cancer patient response to immunotherapy in collaboration with OncoHost
OncoHost’s AI-Based proteomic profiling platform, PROphet, to serve key role in host response evaluation of late-stage disease patients